Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnesium-dependent enzymes and cation-binding proteins constitute a broad class of proteins that utilize magnesium (Mg2+) as a critical cofactor for biological activity. Magnesium is essential for the function of over 300 enzymes, particularly those involved in phosphate transfer reactions, where it stabilizes the polyphosphate chains of ATP and other nucleotides (NIH Office of Dietary Supplements). This group includes vital enzymes such as DNA polymerases, kinases, and ATPases, which are fundamental to energy metabolism, genomic replication, and cellular signaling (UniProt, KW-0460). Beyond catalysis, magnesium-binding proteins play structural roles in maintaining the conformation of ribosomes and chromatin. Clinically, imbalances in magnesium levels or defects in these proteins are implicated in a wide range of conditions, including cardiac arrhythmias, metabolic syndrome, and neurodegenerative diseases (StatPearls, NBK519036). Therapeutic strategies typically focus on correcting magnesium deficiencies or targeting specific magnesium-dependent transporters and enzymes to manage systemic homeostasis. Drugs like Digoxin and certain diuretics interact with the pathways governed by these proteins, often requiring careful monitoring of magnesium levels to avoid toxicity (PubMed, 26322491). Overall, this category represents a fundamental pillar of biochemistry with significant implications for systemic health and pharmacology.
Magnesium ions act as essential cofactors by stabilizing negative charges on phosphate groups in ATP or DNA, facilitating nucleophilic attacks, or maintaining the structural integrity of the protein's active site (StatPearls, NBK519036). Drugs targeting these systems often act by supplementing the cation, competing for binding sites, or altering the renal handling of magnesium.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnesium-dependent enzymes and cation-binding proteins.